|
MOTLEY ASKS ABOUT SANDEFUR’S INVOLVEMENT IN THE DEVELOPMENT OF A “SAFER CIGARETTE” Q. Now, sir, pursuant to the Case Management Order --
Will this be on the TV for the jury or the judge or whoever sees it?
Do you see where I have highlighted where Mr. Sandefur swore to tell the truth under oath under penalty of perjury what he told the Congress of the United States?
MR. BEZANSON: Object to the form.
MR. MOTLEY:
Q. Do you see what he said, sir?
A. Yes, I do.
Q. He said, "I do not believe that nicotine is addictive." Do you see that?
A. Yes I do.
Q. Is that the opposite, contrary to what he has expressed to you numerous times?
A. That is correct.
MR. BEZANSON: Object to the form.
MR. MOTLEY:
Q. It is not true, is it?
A. It is not true.
Q. Did you have any discussions, sir, with Mr. Sandefur -- By the way, Mr. Sandefur was a sales guy, wasn't he? He wasn't a lawyer, correct?
A. Was he a lawyer? No, he wasn't.
Q. He was a salesman at one time for R. J. Reynolds?
A. Yes, he was.
Q. Now, can you tell me, sir, whether Mr. Sandefur at any time sought to keep you, Jeffrey Wigand, from attempting to develop or conduct research that would lead to the development and marketing of what you have described as a safer cigarette?
MR. BEZANSON: Object to the form.
A. Yes.
MR. MOTLEY:
Q. Will you describe how he did it as best you can?
A. Shortly after the Vancouver meeting, Sandefur called me to his office and told me that there would be no further discussion or efforts on any issues related to a safer cigarette, even though there was research being conducted in both Canada and in the U.K. in removing selectively noxae.
Q. That's the term you defined earlier as poisonous substance?
A. Tar.
Q. Okay.
A. And that any activity or elusion [allusion] to a safer cigarette would be deathly contrary to the company's position relative to liability issues associated with smoking and health issues and that that matter would not be pursued any further and I was not to discuss it anymore. He also told me at that time there will be no scientific and medical advisory committee to provide direction or support to the development of a safer cigarette.
MR. MOTLEY:
Q. Dr. Wigand, were you a designee or representative of Brown & Williamson who was to attend certain industry tobacco-industry-wide trade association meetings?
A. From time to time, yes.
Q. Were you allowed to go -- Those are meetings to discuss scientific matters?
A. That's correct.
Q. Were you allowed to go to those meetings alone, or were you required to take some kind of person with you?
A. Depends on the type of meeting. A number of times I went to meetings, particularly on ignition propensity, I was accompanied by a lawyer.
Q. Ignition propensity?
A. Ignition propensity.
Q. Is that sometimes called a fire safe cigarette?
A. Fire safe cigarette, yes.
Q. And they sent a lawyer with you?
A. That's correct.
Q. Was this lawyer a scientist?
A. No, he was not.
|
